Pacira BioSciences, Inc. (NASDAQ:PCRX) Q3 2022 Earnings Conference Call November 3, 2022 8:30 AM ET Company Participants Susan Mesco - Head, Investor Relations Dave Stack - Chairman & Chief Executive Officer Roy Winston - Chief Medical Officer Charlie Reinhart - Chief Financial Officer Conference Call Participants Gregory Renza - RBC Capital Markets Serge Belanger - Needham Gary Nachman - BMO Capital Markets Susan Mesco Good morning everyone. Welcome to today's conference call to discuss our Third Quarter ...

Pacira Biosciences Inc. (NASDAQ:PCRX) Q2 2022 Results Conference Call August 3, 2022 8:30 AM ET Company Participants Susan Mesco - Head, IR Dave Stack - Chairman, CEO Charlie Reinhart - CFO Conference Call Participants David Amsellem - Piper Sandler Chris Neyor - JP Morgan Balaji Prasad - Barclays Gregory Renza - RBC Capital Markets Greg Fraser - Truist Securities Serge Belanger - Needham Operator Ladies and gentlemen, thank you for standing by, and welcome to the Pacira BioScience's Second Quarter 2022 Ear ...

Pacira BioSciences, Inc. (NASDAQ:PCRX) Q1 2022 Earnings Conference Call May 4, 2022 8:30 AM ET Company Participants Susan Mesco – Head-Investor Relations Dave Stack – Chairman and Chief Executive Officer Charlie Reinhart – Chief Financial Officer Conference Call Participants David Amsellem – Piper Sandler Gregory Renza – RBC Capital Markets Greg Fraser – Truist Securities Anita Dushyanth – Berenberg Capital Serge Belanger – Needham & Company Evan Hua – BMO Capital Operator Thank you for standing by, and wel ...

Pacira BioSciences, Inc. (NASDAQ:PCRX) Q4 2021 Earnings Conference Call February 24, 2022 8:30 AM ET Company Participants Susan Mesco - Investor Relations Dave Stack - Chairman and Chief Executive Officer Charlie Reinhart - Chief Financial Officer Roy Winston - Chief Medical Officer Conference Call Participants David Amsellem - Piper Sandler Nina Wang - RBC Capital Markets David Steinberg - Jefferies Balaji Prasad - Barclays Capital Christopher Neyor - J.P. Morgan Greg Fraser - Truist Securities Operator Go ...

| --- | --- | --- | --- | --- | --- | |--------------------------------------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | Pacira BioSciences | | | | | | | Corporate Presentation February 2022 | | | | | | Forward-looking statements and where to find additional information Any statements in this presentation about Pacira's future expectations, plans, trends, outlook, projections and prospects, and other statements containing the words "believes," "anticipates," "plans, ...

Pacira BioSciences (NASDAQ: PCRX) Corporate Presentation November 2021 Forward-looking statements and where to find additional information Any statements in this communication about Pacira BioSciences, Inc.'s ("Pacira") or Flexion Therapeutics, Inc.'s ("Flexion") future expectations, plans, trends, outlook, projections and prospects, and other statements containing the words "believes," "anticipates," "plans," "estimates," "expects," "intends," "may," "will," "would," "could," "can" and similar expressions, ...

Pacira BioSciences, Inc. (NASDAQ:PCRX) Q3 2021 Earnings Conference Call November 3, 2021 8:30 AM ET Company Participants Susan Mesco - IR Dave Stack - Chairman and CEO Charlie Reinhart - CFO Ronald Ellis - Senior Vice President Conference Call Participants David Amsellem - Piper Sandler Gregory Renza - RBC Capital Markets David Steinberg - Jefferies Balaji Prasad - Barclays Greg Fraser - Truist Securities Anita Dushyanth - Berenberg Capital Christopher Neyor - JPMorgan Serge Belanger - Needham & Company And ...

Pacira BioSciences (NASDAQ: PCRX) Corporate Presentation August 2021 Forward-looking statements 2 Any statements in this presentation about the company's future expectations, plans, trends, outlook, projections and prospects, and other statements containing the words "believes," "anticipates," "plans," "estimates," "expects," "intends," "may," "will," "would," "could," "can" and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1 ...

Q2 2021 Commercial Metrics Overview August 4, 2021 Commercial Overview: Q2 Performance Metrics $30.0 $25.0 $20.0 $15.0 $10.0 $5.0 $- $24.6 $28.2 $- $5.0 $10.0 $15.0 $20.0 $25.0 $30.0 Q1 2021 Q2 2021 Net Sales - Current vs Prior Qtr Dollars in millions 15% 36,697 56,798 - 10,000 20,000 30,000 40,000 50,000 60,000 Q2 2020 Q2 2021 Demand - Current vs Same Qtr Prior Year 55% Zilretta Units 53,089 56,798 - 10,000 20,000 30,000 40,000 50,000 60,000 Q1 2021 Q2 2021 Demand - Current vs Prior Qtr Zilretta Units 7% $ ...

Flexion Therapeutics, Inc. (FLXN) Q2 2021 Earnings Conference Call August 4, 2021 4:30 PM ET Company Participants Scott Young - Vice President, Corporate Communications and Investor Relations Michael Clayman - Chief Executive Officer Melissa Layman - Chief Commercial Officer Fred Driscoll - Chief Financial Officer Conference Call Participants Michael Pagliari - Raymond James Madhu Kumar - Goldman Sachs Daniel Busby - RBC Capital Markets Evan Hua - BMO Capital Markets Serge Belanger - Needham & Company Patri ...